Hassan Abdullahi Yusuf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hassan Abdullahi Yusuf has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Malik Olatunde Oduoye
Department of Research The Medical Research Circle Goma Congo
2 shared publications - Abdulkarim Surajo Abdulkarim
Department of Medicine and Surgery, College of Health Sciences Bayero University Kano Kano State Nigeria
1 shared publication - Abdullahi Adeyemi Adegoke
Department of Pharmacognosy, University of Ibadan, Ibadan 200132, Nigeria
1 shared publication - Abdullahi Nuhu Abdullahi
Bayero University Kano
1 shared publication - Adenike Ebunoluwa Adedayo
Department of Internal Medicine University of Debrecen Debrecen Hungary
1 shared publication - Bridget Uzoamaka Mph Chukwudile
University of Nigeria
1 shared publication
Latest Publications
- 2 August 2024
- Published by Springer Nature
- p. 661-683
Challenges Associated with the Nutritional Status of Traditional and Indigenous Foods in the Global South
- 2 August 2024
- Published by Springer Nature
- p. 661-683
Challenges Associated with the Nutritional Status of Traditional and Indigenous Foods in the Global South
- Open Access
- 4 January 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (1) , e1797
Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations
Introduction: Mass malaria vaccination, rather than vaccinating only children below age 5, has been proven to have the potential to reduce morbidity and mortality among those vaccinated, both young and old. Addressing vaccine scepticism and misinformation is crucial in African nations to build public trust in malaria prevention. Therefore, including a wider range of demographics in vaccine trials is necessary for equitable representation and achieving herd immunity against malaria.Aim: This present article aims to identify some of the obstacles that impede malaria vaccination usage and acceptability in African Nations in combating malaria in the region as it continues to pose a significant global public health problem.Methodology: A literature search was done on the Malaria vaccine between 2000 and 2023. Past and present articles/studies on this topic were consulted on PubMed, Google Scholar, Scopus and Web of Science using the following keywords; “Malaria,” “Vaccines,” “African Nations,” “Obstacles, Strategies,” and “Public Health.”Results: The recently approved RTS, S/AS01, and R21/Matrix‐M™ Malaria vaccines have the potential to prevent numerous deaths and cases of Malaria in Africa. These vaccines Malaria vaccines are cost‐effective in African areas with moderate to high plasmodium falciparum and can be delivered through routine immunization.Conclusion: To combat malaria effectively in African Nations, African leaders need to set up a comprehensive approach that involves; prevention, healthcare access, implementation research strategies towards adoption and acceptance of malaria vaccines in Africa as well as community engagement with the religious leaders, the market women, community heads, schools, as well as students’ union towards the willingness and acceptability of the malaria vaccines among the African populations.
- 4 January 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (1) , e1797
Open AccessUnlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations
Introduction: Mass malaria vaccination, rather than vaccinating only children below age 5, has been proven to have the potential to reduce morbidity and mortality among those vaccinated, both young and old. Addressing vaccine scepticism and misinformation is crucial in African nations to build public trust in malaria prevention. Therefore, including a wider range of demographics in vaccine trials is necessary for equitable representation and achieving herd immunity against malaria.Aim: This present article aims to identify some of the obstacles that impede malaria vaccination usage and acceptability in African Nations in combating malaria in the region as it continues to pose a significant global public health problem.Methodology: A literature search was done on the Malaria vaccine between 2000 and 2023. Past and present articles/studies on this topic were consulted on PubMed, Google Scholar, Scopus and Web of Science using the following keywords; “Malaria,” “Vaccines,” “African Nations,” “Obstacles, Strategies,” and “Public Health.”Results: The recently approved RTS, S/AS01, and R21/Matrix‐M™ Malaria vaccines have the potential to prevent numerous deaths and cases of Malaria in Africa. These vaccines Malaria vaccines are cost‐effective in African areas with moderate to high plasmodium falciparum and can be delivered through routine immunization.Conclusion: To combat malaria effectively in African Nations, African leaders need to set up a comprehensive approach that involves; prevention, healthcare access, implementation research strategies towards adoption and acceptance of malaria vaccines in Africa as well as community engagement with the religious leaders, the market women, community heads, schools, as well as students’ union towards the willingness and acceptability of the malaria vaccines among the African populations.